Song, C., Xing, D., Tan, W., Wei, Q. & Lin, D. Methylenetetrahydrofolate reductase polymorphisms increases risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res. 61, 3272–3275 (2001).
Sun, T. et al. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J. Natl. Cancer Inst. 96, 1030–1036 (2004).
Zhang, X. et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129, 565–576 (2005).
Sun, T. et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat. Genet. 39, 605–613 (2007).
Cui, R. et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 137, 1768–1775 (2009).
Wang, L.D. et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat. Genet. 42, 759–763 (2010).
Abnet, C.C. et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet. 42, 764–767 (2010).
Zheng, S.L. et al. Cumulative association of five genetic variants with prostate cancer. N. Engl. J. Med. 358, 910–919 (2008).
Volinia, S. et al. Genome-wide identification of recessive cancer genes by combinatorial mutation analysis. PLoS ONE 3, e3380 (2008).
Du, J. et al. Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells. Cancer Biol. Ther. 4, 242–247 (2005).
Kroll, T. et al. Molecular characterization of breast cancer cell lines by expression profiling. J. Cancer Res. Clin. Oncol. 128, 125–134 (2002).
Neo, S.Y. et al. Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology 39, 944–953 (2004).
Gou, Y. et al. Ribosomal protein L6 promotes growth and cell cycle progression through upregulating cyclin E in gastric cancer cells. Biochem. Biophys. Res. Commun. 393, 788–793 (2010).
Ostman, A., Hellberg, C. & Bohmer, F.D. Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer 6, 307–320 (2006).
Mohi, M.G. & Neel, B.G. The role of Shp2 (PTPN11) in cancer. Curr. Opin. Genet. Dev. 17, 23–30 (2007).
Cho, Y.S. et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat. Genet. 41, 527–534 (2009).
Levy, D. et al. Genome-wide association study of blood pressure and hypertension. Nat. Genet. 41, 677–687 (2009).
Soranzo, N. et al. A genome-wide meta analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat. Genet. 41, 1182–1190 (2009).
Nancarrow, D. et al. Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays. Cancer Res. 68, 4263–4272 (2008).
Nagayama, K. et al. Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution. Genes Chromosom. Cancer 46, 1000–1010 (2007).
Blyth, K., Cameron, E.R. & Neil, J.C. The RUNX genes: gain or loss of function in cancer. Nat. Rev. Cancer 5, 376–387 (2005).
Planagumà, J. et al. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma. Cancer Res. 64, 8846–8853 (2004).
Hoi, C.S. et al. Runx1 directly promotes proliferation of hair follicle stem cells and epithelial tumor formation in mouse skin. Mol. Cell. Biol. 30, 2518–2536 (2010).
Kadota, M. et al. Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines. PLoS ONE 5, e9201 (2010).
Sakakura, C. et al. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer. Int. J. Cancer 113, 221–228 (2005).
Kylie, L. et al. Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization. Genes Chromosom. Cancer 42, 247–259 (2010).
Du Plessis, L. et al. Mapping of novel regions of DNA gain and loss by comparative genomic hybridization in esophageal carcinoma in the black and colored populations of South Africa. Cancer Res. 59, 1877–1883 (1999).
Zhang, J., Xu, L.G., Han, K.J. & Shu, H.B. Identification of a ZU5 and death domain-containing inhibitor of NF-kappaB. J. Biol. Chem. 279, 17819–17825 (2004).
Xiao, R. & Boehnke, M. Quantifying and correcting for the winner's curse in genetic association studies. Genet. Epidemiol. 33, 453–462 (2009).
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).
Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265 (2005).